Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("JONES, Peter A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 44

  • Page / 2
Export

Selection :

  • and

DNA methylation and cancerJONES, Peter A.Oncogene (Basingstoke). 2002, Vol 21, Num 35, pp 5358-5360, issn 0950-9232, 3 p.Article

DNA methylation and breast carcinogenesisWIDSCHWENDTER, Martin; JONES, Peter A.Oncogene (Basingstoke). 2002, Vol 21, Num 35, pp 5462-5482, issn 0950-9232, 21 p.Article

A blueprint for a human epigenome project : The AACR human epigenome workshopJONES, Peter A; MARTIENSSEN, Robert.Cancer research (Baltimore). 2005, Vol 65, Num 24, pp 11241-11246, issn 0008-5472, 6 p.Article

DNA methylation in cancer: too much, but also too littleEHRLICH, Melanie.Oncogene (Basingstoke). 2002, Vol 21, Num 35, pp 5400-5413, issn 0950-9232, 14 p.Article

Epigenetics in human disease and prospects for epigenetic therapy : Human genomics and medicineEGGER, Gerda; GANGNING LIANG; APARICIO, Ana et al.Nature (London). 2004, Vol 429, Num 6990, pp 457-463, issn 0028-0836, 7 p.Article

Gene silencing in mammalian cells and the spread of DNA methylationTURKER, Mitchell S.Oncogene (Basingstoke). 2002, Vol 21, Num 35, pp 5388-5393, issn 0950-9232, 6 p.Article

5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapyCHRISTMAN, Judith K.Oncogene (Basingstoke). 2002, Vol 21, Num 35, pp 5483-5495, issn 0950-9232, 13 p.Article

Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cellsNGUYEN, Carvell; GANGNING LIANG; NGUYEN, Tudung T et al.Journal of the National Cancer Institute. 2001, Vol 93, Num 19, pp 1465-1472, issn 0027-8874Article

DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies : Clinical results and possible mechanisms of actionLÜBBERT, M.Current Topics in Microbiology and Immunology. 2000, Vol 249, pp 135-164, issn 0070-217XArticle

Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AMLBACH TREPPENDAHL, Marianne; XIANGNING QIU; JENDHOLM, Johan et al.Blood. 2012, Vol 119, Num 1, pp 206-216, issn 0006-4971, 11 p.Article

DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoterHAN HAN; CORTEZ, Connie C; XIAOJING YANG et al.Human molecular genetics (Print). 2011, Vol 20, Num 22, pp 4299-4310, issn 0964-6906, 12 p.Article

Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancerCHATTEDEE, Sunanda J; GEORGE, Ben; GOEBELL, Peter J et al.Journal of pathology. 2004, Vol 203, Num 3, pp 762-770, issn 0022-3417, 9 p.Article

Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2'-deoxycytidineGANGNING LIANG; GONZALES, Felicidad A; JONES, Peter A et al.Cancer research (Baltimore). 2002, Vol 62, Num 4, pp 961-966, issn 0008-5472Article

The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. CommentaryWIDSCHWENDTER, Martin; JONES, Peter A; KWONG, Joseph et al.Clinical cancer research. 2002, Vol 8, Num 1, pp 17-21, issn 1078-0432, 12 p.Article

DNA methylation, genomic imprinting and cancerFEINBERG, A. P.Current Topics in Microbiology and Immunology. 2000, Vol 249, pp 87-99, issn 0070-217XArticle

The role of DNA methylation in modulating epstein-barr virus gene expressionROBERTSON, K. D.Current Topics in Microbiology and Immunology. 2000, Vol 249, pp 21-34, issn 0070-217XArticle

Epigenetic modifications as therapeutic targetsKELLY, Theresa K; DE CARVALHO, Daniel D; JONES, Peter A et al.Nature biotechnology (Print). 2010, Vol 28, Num 10, pp 1069-1078, issn 1087-0156, 10 p.Article

Activation of p16 Gene Silenced by DNA Methylation in Cancer Cells by Phosphoramidate Derivatives of 2'-DeoxyzebularineYOO, Christine B; VALENTE, Rocco; CONGIATU, Costantino et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 23, pp 7593-7601, issn 0022-2623, 9 p.Article

Epigenetics and microRNAsCHUANG, Jody C; JONES, Peter A.Pediatric research. 2007, Vol 61, Num 5, pp 24-29, issn 0031-3998, 6 p., 2Article

Overview of cancer epigeneticsJONES, Peter A.Seminars in hematology. 2005, Vol 42, Num 3, pp S3-S8, issn 0037-1963, SUP2Article

Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patientsFRIEDRICH, Martin G; WEISENBERGER, Daniel J; NICHOLS, Peter W et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7457-7465, issn 1078-0432, 9 p.Article

The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cellsPAO, Martha M; TSUTSUMI, Masakazu; LIANG, Gangning et al.Human molecular genetics (Print). 2001, Vol 10, Num 9, pp 903-910, issn 0964-6906Article

Mammalian methyltransferases and methyl-cpG-binding domains : Proteins involved in DNA methylationHENDRICH, B; BIRD, A.Current Topics in Microbiology and Immunology. 2000, Vol 249, pp 55-74, issn 0070-217XArticle

Promoter-region hypermethylation and gene silencing in human cancerHERMAN, J. G; BAYLIN, S. B.Current Topics in Microbiology and Immunology. 2000, Vol 249, pp 35-54, issn 0070-217XArticle

DNA methylation and cancerJONES, Peter A; VOGT, Peter K.Current Topics in Microbiology and Immunology. 2000, Vol 249, issn 0070-217X, 170 p.Serial Issue

  • Page / 2